Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 2/20 | 0.37 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.37 |
| ▸ | GLB1 | P16278 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22196099 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL14153817 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL10038592 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL1964139 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL18965309 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL24268893 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL6852230 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL19228704 | 0.96 | GBA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 | |
| SCHEMBL20691251 | 0.89 | FUCA1 (0.35) | GBA1GLAFUCA1GLB1GAA | |
| SCHEMBL15484275 | 0.88 | FUCA1 (0.39) | GBA1GLAFUCA1GLB1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9359324-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-07-16 | — | — | US | disclosed |
| US-9051293-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197501-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | GBA1 4164/4885GLA 4177/4885FUCA1 3703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.